LXEO · Lexeo Therapeutics, Inc.

NasdaqHealthcareBiotechnology

Lexeo Therapeutics Inc Is A Clinical-Stage Genetic Medicine Company Engaged In The Development Of Gene Therapy Candidates Targeting The Underlying Genetic Causes Of Cardiovascular Diseases. The Company Is Advancing A Portfolio Of Programs Focused On Conditions Such As Friedreich Ataxia, Cardiomyopathy, Plakophilin-2, Or Pkp2, And Arrhythmogenic Cardiomyopathy, With Its Lead Candidates Including Lx2006 And Lx2020. Its Therapies Utilize Aav-Based Vectors Designed To Deliver Functional Genes To Cardiac Cells To Restore Normal Function And Address High Unmet Medical Needs.

HealthcareNasdaqUS

FLOAT

76.6M

FREE FLOAT %

93%

SHARES O/S

82.0M

MARKET CAP

$229.8M

EXCHANGE

Nasdaq

COUNTRY

LXEO Catalyst History

No catalysts recorded for LXEO yet

Day Trader Sniper hasn't classified a publishable catalyst for LXEO yet. New events appear here as they're scored.

Be early on the next LXEO spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

LXEO · Lexeo Therapeutics, Inc.

LXEO Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.